UOC
MRK icon

UBS O'Connor’s Merck MRK Stock Holding History

UBS O'Connor’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,790
Closed -$596K – 571
2023
Q3 		$596K Hold
5,790
– – 0.01% 387
2023
Q2 		$668K Sell
5,790
-12,074
-68% -$1.37M 0.01% 423
2023
Q1 		$1.9M Buy
17,864
+14,303
+402% +$1.54M 0.05% 327
2022
Q4 		$395K Sell
3,561
-19,239
-84% -$1.97M 0.01% 629
2022
Q3 		$1.96M Buy
+22,800
New +$2.04M 0.02% 627
2017
Q3 		– Sell
-44,280
Closed -$2.71M – 405
2017
Q2 		$2.71M Buy
+44,280
New +$2.7M 0.04% 234
2013
Q3 		– Sell
-109,097
Closed -$4.83M – 520
2013
Q2 		$4.83M Buy
+109,097
New +$4.87M 0.09% 243

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS O'Connor's MRK Position: Q4 2023 in Review

UBS O'Connor sold out of Merck (MRK) in Q4 2023, closing a stake of 5,790 shares — an estimated $596K sold.

UBS O'Connor first reported a position in MRK in Q2 2013 and held it in 7 quarters. The position peaked at $4.83M in Q2 2013. 3,439 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

  • UBS O'Connor reported no remaining Merck position as of Q4 2023 after selling out during the quarter.
  • UBS O'Connor sold 5,790 Merck shares in Q4 2023, an estimated $596K.
  • UBS O'Connor first reported a position in Merck in Q2 2013 and held it in 7 quarters.
  • UBS O'Connor's Merck position peaked at $4.83M in Q2 2013.
  • 3,439 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.